Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release

Structural Variant Detection, De Novo Assembly and Targeted Sequencing Applications Improved MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system's ability to support important applications such as structural variant detection and targeted sequencing— including [...]

Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

SAN DIEGO & HERCULES, Calif.-- Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. [...]

IBM and Illumina Partner to Standardize Genomic Data Interpretation

Data interpretation from Watson will help users translate genomic data  from  Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO - IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to  expand access to genome data interpretation by integrating Watson for Genomics into  Illumina’s BaseSpace Sequence Hub and tumor sequencing [...]

Philips and Illumina join forces to offer integrated genomics solutions for oncology

Collaboration aims to leverage Illumina’s  world-class DNA sequencing technology and BaseSpace Sequence Hub with Philips’ innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research Amsterdam, the Netherlands, and  San Diego, US - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA [...]

PerkinElmer to Acquire Tulip Diagnostics Private Limited in India

Extends PerkinElmer's Infectious Disease Screening Capabilities Supports Company's Growth in Emerging Market Diagnostics WALTHAM, Mass.-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd. Based in Goa, India, Tulip is one of the country's largest domestic providers of in-vitro diagnostic [...]

Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year Ended December 31, 2016

SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the [...]

Pall ForteBio Acquires the Pioneer SPR Product Line from SensiQ Technologies to Expand Its Label-Free Interaction Analysis Portfolio

Pall ForteBio acquires the Pioneer SPR Platform from SensiQ Technologies, expanding its portfolio of BLI-based biomolecular characterization instruments to include SPR-based small molecule fragment screening and more detailed biologics characterization. Freemont, CA Pall ForteBio, the developer and provider of industry-leading label-free biosensor technology platform, today announced that they will acquire the assets related to SensiQ’s [...]

Bioline Launches the Full Range of EPIK™ miRNA Assays

CINCINNATI -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of the EPIK™ miRNA Select Assays, originally developed for the study of individual microRNA (miRNA) molecules. In collaboration with MiRXES, Bioline released 800 EPIK™ miRNA Select Assays in March 2016 and this has now been increased to include all of the organisms [...]

Gore announces launch of GORE™ Protein Capture Device with Protein A for Rapid mAb Purification at PepTalk

  ELKTON, Md. -- Gore today announced the launch of a new line ofGORE™ Protein Capture Devices with Protein A, intended for drug discovery and research applications, which fundamentally improves the purification process of monoclonal antibodies.  The announcement came at PepTalk, Protein Science Week, one of the largest annual gatherings of protein science researchers in the world, [...]

QIAGEN enhances bioinformatics portfolio with acquisition of OmicSoft

Powerful multi-omics data management solution and highly curated ‘omics’ data sets complement QIAGEN’s industry-leading interpretation solutions Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that [...]

Access IBO on Knowledge Center